Dina Polosukhina*, Harold D. Love*†, Harold L. Moses‡§¶#, Ethan Lee**††, Roy Zent†§**‡‡, Peter E. Clark*‡
Oncology Research, Vol.25, No.9, pp. 1653-1664, 2017, DOI:10.3727/096504017X14992942781895
Abstract Wilms tumor (WT) is the most common renal malignancy in children and the fourth most common pediatric
solid malignancy in the US. Although the mechanisms underlying the WT biology are complex, these tumors
most often demonstrate activation of the canonical Wnt/β-catenin pathway. We and others have shown that
constitutive activation of β-catenin restricted to the renal epithelium is sufficient to induce primitive renal
epithelial tumors, which resemble human WT. Here we demonstrate that pharmacologic inhibition of β-catenin
gene transcription with pyrvinium inhibits tumor growth and metastatic progression in a murine model of WT.
Cellular invasion More >